T

Translational Research in Oncology

Translational cancer research in clinical trials

Clinical Research Associate

Clinical Research OperationsConfirmed live in the last 24 hours
ContractRemote in ArgentinaNo salary listed

About the Job

Requirements

  • A minimum of 2 years of monitoring experience in oncology trials.
  • Completion of a science-related Bachelor's degree.
  • Excellent knowledge of medical terminology and the clinical monitoring process.
  • Strong knowledge of International Council for Harmonisation Good Clinical Practice (ICH-GCP).
  • Experience with clinical trial information systems.
  • Ability to travel up to 60% on average.
  • Bilingualism in English and Spanish is required.

Responsibilities

  • Perform data verification of source documents.
  • Conduct site visits, including pre-study, initiation, monitoring, and termination visits.
  • Confirm adherence to all Food and Drug Administration (FDA), International Council for Harmonisation Good Clinical Practice (ICH-GCP), and local regulations.
  • Ensure implementation and compliance with FDA and ICH-GCP guidelines.
  • Participate in budget negotiation and follow-up where applicable.
  • Assist with data validation and query resolution.
  • Mentor junior team members as required.
  • Ensure completion and collection of regulatory documents.

Desired Qualifications

  • Experience monitoring early-phase trials is valued.

About the Company

Translational Research in Oncology

Translational cancer research in clinical trials

TRIO is an academic clinical research organization focused on translating cancer science into patient treatments. It coordinates translational cancer research by bringing innovative, targeted therapeutic ideas into clinical trials. The group operates through an international network, with offices in Canada, France, and Uruguay and partnerships with about 2,000 investigators and 450 cancer centers in more than 45 countries, allowing global studies of systemic cancer therapies. Compared with typical biotech or pharma firms, TRIO emphasizes academic collaboration and real-world trial execution across many centers rather than developing and selling drugs itself. Its goal is to move promising cancer treatments from the lab to the clinic, testing them in trials to improve outcomes for patients.

Company size
201-500
Company stage
Not listed
Total funding
Not listed
Headquarters
Edmonton, Canada
Founded
1997

Recently Posted Jobs

Explore more opportunities at Translational Research in Oncology

See more jobs